Financials and Inverse S&P 500: 2 ETFs to Watch on Outsized Volume

QQQ SPY DIA

In the last trading session, U.S. stocks were slightly positive after a bloodbath the day earlier as investors await the outcome of Trump’s Health Care plan voting. Among the top ETFs, investors saw SPY gain over 0.2%, and DIA add about 0.03% and QQQ move higher by 0.7% on the day.

Two more specialized ETFs are worth noting as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average in the most recent trading session. This could make these ETFs the ones to watch out for in the days ahead to see if this trend of extra-interest continues:

KBE: Volume 3.48 times average

This financial ETF was in the spotlight yesterday as nearly 9 million shares moved hands compared with an average of roughly 2.59 million shares a day. We also saw some price movement as KBE lost nearly 0.40% last session.

The movement can largely be due to a slower rate hike trajectory guided by the Fed for this year. This can have a huge impact on financial stocks – that perform well in a rising rate environment– like what we find in this ETF portfolio. KBE was down 8.3% in the past one month and has a Zacks ETF Rank of 1 or ‘Strong Buy’ rating with a High risk outlook.

SH: Volume 2.49 times average

This inverse S&P 500 ETF was under the microscope yesterday as more than 3.97 million shares moved hands. This compares with an average trading day of around 1.60 million shares and came as SH shed about 0.14% in the session. SH, however, gained 0.5% in the past one month.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>